DISCOUNT ZERTIFIKAT - MEDTRONIC Stock

Certificat

DE000PN6ANR9

Market Closed - Deutsche Boerse AG 03:40:11 2024-06-07 pm EDT
62.4 EUR +0.94% Intraday chart for DISCOUNT ZERTIFIKAT - MEDTRONIC
Current month+1.04%
1 month+0.95%
Date Price Change
24-06-07 62.4 +0.94%
24-06-06 61.82 +0.02%
24-06-05 61.81 -0.05%
24-06-04 61.84 +0.42%
24-06-03 61.58 -0.29%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN6ANR
ISINDE000PN6ANR9
Date issued 2023-07-25
Maturity 2024-12-20 (196 Days)
Parity 1 : 1
Emission price 56.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 62.4
Lowest since issue 55.41
Spread 0.1
Spread %0.16%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
84.07 USD
Average target price
94.07 USD
Spread / Average Target
+11.89%
Consensus